FV leiden mutation and deep venous thrombosis in vojvodina: A case-control study

Journal of Medical Biochemistry

Volumn 30, Issue 1, 2011, Pages 51-54

  Salatić, Iva ^a   Kiralj, Katarina ^b   Mitić, Gorana ^a   Veselinović, Igor ^a   Vapa, Dušan ^a  

^a CLINICAL CENTER OF VOJVODINA   (Serbia)

^b Clinic for infectious diseases   (Serbia)

Author keywords

deep vein thrombosis; factor V Leiden

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN;

ARTICLE; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; GENE MUTATION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK;

EID: 78649640615     PISSN: 14528258     EISSN: 14528266     Source Type: Journal    
DOI: 10.2478/v10011-010-0050-7     Document Type: Article

References (15)

1. Mili D. Disorders of the coagulation system in the patients with deep vein thrombosis of lower extremities. Acta biologica iugoslavica 2000; 1: 43-56.
2. Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov N P, Boulyjenkov V, Chandy M, et al. Inherited Throm bophilia: Part l. Thrombosis and Haemostasis 1996; 76: 651-62.
3. Franco R F, Reitsma PH. Genetic risk factors of venous thrombosis. Human Genetics 2001; 109: 369-84.
4. Rizk N, Toon PG, Watson D, Jones V. Protein S deficiency and factor V Leiden gene in pregnancy. Journal of Obstetrics and Gynaecology 1998; 2: 178-9.
5. Mandalà M, Curigliano G, Bucciarelli P, Ferretti G, Mannucci PM, Colleoni M, et al. Factor V Leiden and G20210A prothrombin mutation and the risk of subclavian vein thrombosis in patients with breast cancer and a central venous catheter. Annals of Oncology 2004; 15 (4): 590-3.
6. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, De Ronde H, Van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-7.
7. Miti G. Nasledna trombofilijaitrombozne kompli kacije u trudnoći [disertacija]. [Novi Sad]: Univerzitet u Novom Sadu; 2008; 147.
8. Angelopoulou K, Nicolaides A, Constantinou DC. Preva lence of genetic mutations that predispose to thrombophilia in a Greek Cypriot population. Clin Appl Thromb Hemost 2000; 6 (2): 104-7.
9. Franco R F. Heterogeneous ethnic distribution of the factor v leiden mutation. Genet Mol Biol 1999; 22 (2): 143-5.
10. Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med 2001; 344: 1222-31.
11. Leonard DGB, Bagg A. Molecular pathology in clinical practice. Springer 2006: 145-6pp. [Internet]. [Cited June 2010] Available at http://www. springerlink.com/content/w67t13/.
12. Mei J V, Alexander RJ, Adam BW, Hannon WH. Use of filter paper for the collection and analysis of human whole blood specimens. Journal of Nutrition 2001; 131: (163): 1-6.
13. Kovǎ M, Mikovi D, Antonijevi N, Rakǐevi Lj, Dordevi V, Radojkovi D, Elezovi I. FV Leiden mutation and risk of recurrent venous thromboembolism in Serbian population. J Thromb Thrombolysis 2008; 25: 284-7.
14. Kearon C, Crowther M, Hirsh J. Management of patients with hereditary hypercoagulable disorders. Annu Rev Med 2000; 51: 169-85.
15. Hirsh J, Kearon C, Ginsberg J. Duration of anti coa gulation therapy after first episode of venous thrombosis in patients with inherited thrombophilia. Arch Intern Med 1997; 157: 2174-7.